HALO logo
halo search icon
Vertex Pharmaceuticals Incorporated

US$447.54

Price Change Indicator
-0.43 (-0.096%)
Vertex Pharmaceuticals Incorporated
VRTX · NAS

Vertex Pharmaceuticals Incorporated

Start Trading VRTX for Free

US$447.54

Price Arrow-0.43 (-0.096%)
29/05/2026 04:15:00 PM
All-CompaniesAll-ConsensusALL-RecommendationsEngulfing BullishHALO 200HALO 500HALO AllHALO Balance Sheet+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Vertex Pharmaceuticals Incorporated Overview

VRTX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Neutral

Garp

Neutral

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

About VRTX

icon
icon

Telephone

1.617.341.6100

icon

Address

50 Northern Avenue, Boston, MA 02210

Description

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

VRTX Price Chart

Key Stats

Market Cap

US$113.70B

PE

29.60

EV/EBITDA

22.2

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 362.5 - 507.92

Trade Value (12mth)

US$159,570,917.00

1 week

3%

1 month

4.72%

YTD

-1.02%

1 year

1.24%

All time high

519.88

Key Fundamentals

EPS 3 yr Growth

19.20%

EBITDA Margin

41.10%

Operating Cashflow

$3,631m

Free Cash Flow Return

18.80%

ROIC

20.40%

Interest Coverage

373.50

Quick Ratio

2.50

Other Data

Shares Outstanding (Fully Diluted)

256m

HALO Sector

Healthcare

Next Company Report Date

09-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

VRTX Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
14 May 26
14 May 26

VRTX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock14.05-2.0815.46locklocklock
EPS (Fully Diluted)
 $locklocklocklock13.89-2.0815.32locklocklock
Growth
 %locklocklocklock8.3-114.8844.4locklocklock
PE
 Xlocklocklocklock29.3N/A29.6locklocklock
EV/EBITDA
 Xlocklocklocklock21.421.422.2locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
The current share price of Vertex Pharmaceuticals Incorporated (VRTX:NAS) is USD$447.54.
What is the 52-week high share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
The 52-week high share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS) is USD$507.92.
What is the 52-week low share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
The 52-week low share price for Vertex Pharmaceuticals Incorporated (VRTX:NAS) is USD$362.50.
What is the dividend yield for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) does not pay a dividend.
What was Vertex Pharmaceuticals Incorporated (VRTX:NAS) last dividend payment?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) does not pay a dividend.
What is the franking level for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) has a franking level of 0.00%.
In which sector is Vertex Pharmaceuticals Incorporated (VRTX:NAS) classified?
Halo FAQ
Vertex Pharmaceuticals Incorporated (VRTX:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Vertex Pharmaceuticals Incorporated (VRTX:NAS)?
Halo FAQ
The current P/E ratio for Vertex Pharmaceuticals Incorporated (VRTX:NAS) is 29.60.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial